Cargando…

Longevity and Mechanism of Heterosubtypic Protection Induced by M2SR (M2-Deficient Single-Replication) Live Influenza Virus Vaccine in Mice

Seasonal influenza and the threat of global pandemics present a continuing threat to public health. However, conventional inactivated influenza vaccines (IAVs) provide little cross-protective immunity and suboptimal efficacy, even against well-matched strains. Furthermore, the protection against mat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sarawar, Sally, Gabaglia, Claudia R., Sanchez, Adriana, Hatta, Yasuko, Dias, Peter, Neumann, Gabriele, Kawaoka, Yoshihiro, Bilsel, Pamuk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781428/ https://www.ncbi.nlm.nih.gov/pubmed/36560540 http://dx.doi.org/10.3390/vaccines10122131

Ejemplares similares

Quadrivalent Formulation of Intranasal Influenza Vaccine M2SR (M2-Deficient Single Replication) Protects against Drifted Influenza A and B Virus Challenge
por: Hill-Batorski, Lindsay, et al.
Publicado: (2023)

Safety and Immunogenicity of M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR) in Adults
por: Eiden, Joseph, et al.
Publicado: (2021)

Intranasal M2SR (M2-Deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies in Adults
por: Eiden, Joseph, et al.
Publicado: (2022)

10. Quadrivalent M2SR (M2-deficient Single Replication) Live Influenza Vaccine Provides Better Protection Than Inactivated Vaccine Against Drifted Influenza B Virus Challenge in Ferrets
por: Hill-Batorski, Lindsay, et al.
Publicado: (2021)

1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults
por: Eiden, Joseph, et al.
Publicado: (2018)

2748. Single Intranasal (IN) Dose of M2SR (M2-Deficient Single Replication) Live Influenza Vaccine Protects Adults Against Subsequent Challenge with a Substantially Drifted H3N2 Strain
por: Eiden, Joseph, et al.
Publicado: (2019)

M2-Deficient Single-Replication Influenza Vaccine–Induced Immune Responses Associated With Protection Against Human Challenge With Highly Drifted H3N2 Influenza Strain( )
por: Eiden, Joseph, et al.
Publicado: (2021)

33. Intranasal M2SR (M2-deficient Single Replication) Live H3N2 Influenza Investigational Vaccine Induces Serum HAI & Broad Immune Responses in High Proportion of Adults
por: Eiden, Joseph, et al.
Publicado: (2020)

Intranasal Single-Replication Influenza Vector Induces Cross-Reactive Serum and Mucosal Antibodies against SARS-CoV-2 Variants
por: Moser, Michael J., et al.
Publicado: (2023)

1155. Coadministration of Intranasal M2SR (M2-deficient Single Replication) Investigational Influenza Vaccine with Fluzone High Dose Induces Superior Immune Responses to Fluzone High Dose Alone in 65-85 Year Old Adults
por: Eiden, Joseph, et al.
Publicado: (2023)

An M2e-based synthetic peptide vaccine for influenza A virus confers heterosubtypic protection from lethal virus challenge
por: Ma, Ji-Hong, et al.
Publicado: (2013)

Viral Replication Rate Regulates Clinical Outcome and CD8 T Cell Responses during Highly Pathogenic H5N1 Influenza Virus Infection in Mice
por: Hatta, Yasuko, et al.
Publicado: (2010)

Insights into CD8 T Cell Activation and Exhaustion from a Mouse Gammaherpesvirus Model
por: Sarawar, Sally R., et al.
Publicado: (2020)

mTORC2 takes the longevity stAGE
por: Lamming, Dudley W.
Publicado: (2014)

Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice
por: Chowdhury, Mohammed YE, et al.
Publicado: (2014)

An mRNA-based broad-spectrum vaccine candidate confers cross-protection against heterosubtypic influenza A viruses
por: Xiong, Feifei, et al.
Publicado: (2023)

mTORC2-SGK-1 acts in two environmentally responsive pathways with opposing effects on longevity
por: Mizunuma, Masaki, et al.
Publicado: (2014)

Hypothalamic mTORC2 is essential for metabolic health and longevity
por: Chellappa, Karthikeyani, et al.
Publicado: (2019)

Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus
por: Hatta, Masato, et al.
Publicado: (2018)

SARS-CoV-2 Interference of Influenza Virus Replication in Syrian Hamsters
por: Halfmann, Peter J, et al.
Publicado: (2021)

Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1
por: Berthoud, Tamara K., et al.
Publicado: (2011)

A cell-based screening system for influenza A viral RNA transcription/replication inhibitors
por: Ozawa, Makoto, et al.
Publicado: (2013)

Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge
por: Magini, Diletta, et al.
Publicado: (2016)

Host Range Restriction and Pathogenicity in the Context of Influenza Pandemic
por: Neumann, Gabriele, et al.
Publicado: (2006)

The first influenza pandemic of the new millennium
por: Neumann, Gabriele, et al.
Publicado: (2011)

Predicting the Next Influenza Pandemics
por: Neumann, Gabriele, et al.
Publicado: (2019)

Quo Vadis Influenza?
por: Neumann, Gabriele, et al.
Publicado: (2021)

Seasonality of influenza and other respiratory viruses
por: Neumann, Gabriele, et al.
Publicado: (2022)

The COVID-19 Pandemic—A Potential Role for Antivirals in Mitigating Pandemics
por: Neumann, Gabriele, et al.
Publicado: (2023)

Which Virus Will Cause the Next Pandemic?
por: Neumann, Gabriele, et al.
Publicado: (2023)

Multi-Dimensional Measurement of Antibody-Mediated Heterosubtypic Immunity to Influenza
por: Wang, Jiong, et al.
Publicado: (2015)

Targeted Alteration of Antibody-Based Immunodominance Enhances the Heterosubtypic Immunity of an Experimental PCV2 Vaccine
por: Rakibuzzaman, AGM, et al.
Publicado: (2020)

Intranasal vaccination with M2e5x virus-like particles induces humoral and cellular immune responses conferring cross-protection against heterosubtypic influenza viruses
por: Lee, Young-Tae, et al.
Publicado: (2018)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
por: Folegatti, Pedro M., et al.
Publicado: (2019)

Functional Analysis of Conserved Motifs in Influenza Virus PB1 Protein
por: Chu, Caroline, et al.
Publicado: (2012)

Red, Green, and Blue Photoluminescence of Ba(2)SiO(4):M (M = Eu(3+), Eu(2+), Sr(2+)) Nanophosphors
por: Streit, Huayna Cerqueira, et al.
Publicado: (2013)

Octa-coordinated alkaline earth metal–dinitrogen complexes M(N(2))(8) (M=Ca, Sr, Ba)
por: Wang, Qian, et al.
Publicado: (2019)

Luminescent Afterglow Behavior in the M(2)Si(5)N(8): Eu Family (M = Ca, Sr, Ba)
por: Van den Eeckhout, Koen, et al.
Publicado: (2011)

mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021
por: McLean, Huong Q., et al.
Publicado: (2022)

Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti–Influenza A Antibodies
por: Sui, Jianhua, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ruqefo7pmapq9jm206ce2aald5